BRIDGE & Friends Trial
Weight Management and Black American Women: Targeting Social Networks as a Strategy to Improve Outcomes (BRIDGE & Friends)
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 50 Years to 79 Years
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study compares two Mediterranean diet programs for adults ages 50–79 with obesity. The programs last 6 months and include 24 sessions, with progress checked through 12 months. Researchers will study changes in weight, body fat, diet, and activity, and how sharing information affects people in participants’ social circles.
Aim 1. Conduct a 6-month (24-session) RCT comparing MedDiet-WL to MedDiet-SN among 268 older adults with obesity (50-79 years, BMI = 30-50 kg/m²). We hypothesize that 1) Participants in MedDiet-SN will show improvements in bodyweight/BMI and body fat compared to MedDiet-WL at post-intervention (6-months), 2) Participants in MedDiet-SN will show improvements in diet (diet quality) and physical activity (step counts) compared to MedDiet-WL at post-intervention (6-months), and 3) Participants in MedDiet-SN will maintain these improvements at 12-months. Aim 2. Characterize and compare differences in weight management information dissemination by 268 randomized to MedDiet-WL and MedDiet-SN. We hypothesize that MedDiet-SN participants will share information to more network members compared to participants in MedDiet-WL. Aim 3. Compare MedDiet-SN and MedDiet-WL in 268 network members. We hypothesize that MedDiet-SN network members will show, greater improvements in BMI, body fat, diet, and physical activity than MedDiet-WL network members at 6 months. We will explore how effects may vary by network (e.g., density, relationships), and messaging characteristics (e.g., modality).
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Are 50–79 years old.
- Have a BMI of 30–50. BMI is a measure of weight compared with height.
- Are willing to take part in all study activities.
- Understand English.
- Are willing to change your diet and lifestyle.
- Have access to a phone.
- Plan to live in the Chicago area for the next 12 months.
Who can't join
- Have severe heart disease caused by poor blood flow to the heart.
- Have severe lung disease.
- Have had weight-loss surgery.
- Have received cancer treatment in the past 12 months.
- Already follow a Mediterranean diet, based on a diet screening.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * 50-79 yrs old, * BMI 30-50 * Willing to participate in all procedures * Understand English * Willing to make changes to diet and lifestyle * Have access to a phone * Plan to reside in the Chicago area for the next 12 months Exclusion Criteria: * Severe ischemic heart disease * Severe pulmonary disease * Bariatric surgery * Cancer treatment within the past 12 months * Current adherence to MedDiet based on dietary screening
Study sites (1)
IL
- University of Illinois Chicago · Chicago, IL 60608Lara Blumstein, MA · Study contact · 7734903311 · larabeth99@yahoo.comMarian Fitzgibbon, PhD · Study contact · 3129969028 · mlf@uic.eduMore trials in Chicago